Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50,000
Closed -$17.6M 1806
2026
Q1
$17.6M Buy
+50,000
New +$17.8M 0.13% 117
2025
Q2
Sell
-11,500
Closed -$3.58M 1496
2025
Q1
$3.58M Buy
11,500
+2,000
+21% +$591K 0.11% 90
2024
Q4
$2.48M Sell
9,500
-7,000
-42% -$2.08M 0.05% 234
2024
Q3
$5.32M Buy
16,500
+6,000
+57% +$1.96M 0.11% 172
2024
Q2
$3.28M Buy
10,500
+3,500
+50% +$1.03M 0.06% 239
2024
Q1
$1.99M Sell
7,000
-3,500
-33% -$1.02M 0.05% 354
2023
Q4
$3.02M Sell
10,500
-35,800
-77% -$9.75M 0.07% 258
2023
Q3
$12.4M Buy
46,300
+33,300
+256% +$8.31M 0.27% 53
2023
Q2
$2.89M Sell
13,000
-12,600
-49% -$2.92M 0.06% 290
2023
Q1
$6.19M Sell
25,600
-16,000
-38% -$3.93M 0.15% 141
2022
Q4
$10.9M Sell
41,600
-2,100
-5% -$563K 0.31% 57
2022
Q3
$9.85M Buy
43,700
+9,600
+28% +$2.33M 0.19% 63
2022
Q2
$8.3M Buy
34,100
+9,000
+36% +$2.21M 0.2% 72
2022
Q1
$6.07M Buy
25,100
+20,100
+402% +$4.62M 0.12% 121
2021
Q4
$1.13M Buy
+5,000
New +$1.06M 0.02% 575
2021
Q1
Sell
-1,000
Closed -$230K 1135
2020
Q4
$230K Hold
1,000
0.01% 739
2020
Q3
$254K Sell
1,000
-800
-44% -$198K 0.02% 518
2020
Q2
$425K Sell
1,800
-12,500
-87% -$2.85M 0.03% 328
2020
Q1
$2.9M Sell
14,300
-13,600
-49% -$2.97M 0.13% 113
2019
Q4
$6.72M Buy
+27,900
New +$6.15M 0.33% 66
2019
Q2
Sell
-600
Closed -$114K 424
2019
Q1
$114K Sell
600
-4,900
-89% -$936K 0.01% 285
2018
Q4
$1.07M Sell
5,500
-8,700
-61% -$1.7M 0.08% 135
2018
Q3
$2.94M Buy
14,200
+8,800
+163% +$1.73M 0.25% 60
2018
Q2
$996K Buy
+5,400
New +$955K 0.21% 39

Other funds holding AMGN

Centiva Capital's AMGN Position: Q2 2026 in Review

Centiva Capital increased its Amgen (AMGN) stake by 45% in Q2 2026, buying an estimated $2.83M and bringing the position to 26,442 shares worth $9.58M. The position accounts for 0.08% of the portfolio, ranked #175.

Centiva Capital first reported a position in AMGN in Q4 2018 and has held it in 24 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Centiva Capital held 26,442 shares of Amgen worth $9.58M as of Q2 2026.
  • Centiva Capital bought 8,259 Amgen shares in Q2 2026, an estimated $2.83M.
  • Amgen made up 0.08% of Centiva Capital's portfolio in Q2 2026, its #175 holding.
  • Centiva Capital first reported a position in Amgen in Q4 2018 and has held it in 24 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.